Microdosimetry and radiocurability: Modelling targeted therapy with β-emitters

Physics in Medicine and Biology

Volumn 41, Issue 10, 1996, Pages 1957-1972

  Nahum, Alan E ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BETA RADIATION; CANCER CONTROL; CELL COUNT; MICRODOSIMETRY; NEUROBLASTOMA; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIOSENSITIVITY;

BETA RAYS; COPPER RADIOISOTOPES; HUMANS; IODINE RADIOISOTOPES; MONTE CARLO METHOD; NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; YTTRIUM RADIOISOTOPES;

EID: 0029779319     PISSN: 00319155     EISSN: None     Source Type: Journal    
DOI: 10.1088/0031-9155/41/10/008     Document Type: Article

References (34)

1. 131I and total body irradiation for treatment of disseminated cancer Int. J. Radiat. Oncol. Biol. Phys. 32 713-21
2. Andreo P 1991 Monte Carlo techniques in medical radiation physics Phys. Med. Biol. 36 861-920
3. Bardiès M and Chatal J F 1994 Absorbed doses for internal radiotherapy from 22 betaemitting radionuclides: beta dosimetry of small spheres Phys. Med. Biol. 39 961-81
4. Berger M J 1973 Improved Point Kernels for Electron and Beta Ray Dosimetry NBSIR 73-107 (Washington, DC: National Bureau of Standards)
5. Brahme A 1984 Dosimetric precision requirements in radiation therapy Acta Radiol. Oncol. 23 379-91
6. Deacon J, Peckham M J and Steel G G 1984 The radioresponsiveness of human tumours and the initial slope of the cell survival curve Radiother. Oncol. 2 317-23
7. Flower M A 1994 Dosimetric considerations Nuclear Medicine in Clinical Diagnosis and Treatment ed I P C Murray and P J Ell (London: Churchill Livingstone) pp 71.1-6
8. Gardin I, Faraggi M, Huc, E and Bok B 1995 Modelling of the relationship between cell dimensions and mean electron dose delivered to the cell nucleus: application to five radionuclides used in nuclear medicine Phys. Med. Biol. 40 1001-14
9. Goitein M 1992 The comparison of treatment plans Semin. Radiat. Oncol. 2 246-56
10. Howell R W, Rao D V and Sastry K S R 1989 Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumours Med. Phys. 16 66-74
11. Humm J L 1986 Dosimetric aspects of radiolabeled antibodies for tumor therapy J. Nucl. Med. 27 1490-7
12. Humm J L, Roeske J C, Fisher D R and Chen G T Y 1993 Microdosimetric concepts in radioimmunotherapy Med. Phys. 20 535-41
13. ICRU 1983 Microdosimetry International Commission on Radiation Units and Measurements Report 36 (Bethesda, MD: ICRU)
14. Leichner P K and Kwok C S 1993 Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles Med. Phys. 20 529-34
15. Leichner P K, Yang N-C, Wessels B W, Hawkins W G, Order S E and Klein J L 1990 Dosimetry and treatment planning in radioimmunotherapy Frontiers of Radiation Therapy and Oncology vol 24, ed J M Vaeth and J L Meyer (Basel: Karger) pp 109-22
16. Mohan R, Mageras G S, Baldwin B, Brewster L J and Kulcher G J 1992 Clinically relevant optimisation of 3-D conformal treatments Med. Phys. 19 933-44
17. Nahum A E and Babich J W 1990 The effect of β-particle range on tumour control probability in targeted radionuclide therapy Prog. Abstracts 9th Meeting Eur. Soc. Ther. Radiol. Oncol. (Montecatini Terme) (Leuven: ESTRO) p 131
18. Nahum A E, Babich J W and Moyes J S E 1989 Calculation of tumour control probability in targeted radionuclide therapy. Proc. 17th Int. Congr. Radiol. (Paris, 1989) Abstract
19. Nahum A E and Tait D M 1992 Maximising local control by customised dose prescription for pelvic tumours Advanced Radiation Therapy: Tumour Response Monitoring and Treatment Planning ed A Breit (Heidelberg: Springer) pp 425-31
20. Nimierko A and Goitein M 1993 Implementation of a model for estimating tumor control probability for an inhomogeneously irradiated tumour Radiother. Oncol. 29 140-7
21. O'Donoghue J A, Bardiès M and Wheldon T E 1995 Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides J. Nucl. Med. 36 1902-9
22. 131I- radiolabelled meta-iodobenzylguanidine (mIBG) for the targeted radiotherapy of neuroblastoma Br. J. Radiol. 64 428-34
23. Prestwich W V, Nunes J, Kwok C S 1989 Beta dose point kernels for radionuclides of potential use in radioimmunotherapy J. Nucl. Med. 30 1036-46
24. Sgouros G, Barest G, Thekkumthala J, Chui C, Mohan R, Bigler R E and Zanzonico P B 1990 Treatment planning for internal radionuclide therapy: three-dimensional dosimetry for nonuniformly distributed radionuclides J. Nucl. Med. 31 1884-91
25. Simpkin D J and Mackie T R 1990 EGS4 Monte Carlo determination of the beta dose kernel in water Med. Phys. 17 179-86
26. Steel G G (ed) 1993 Basic Clinical Radiobiology (Sevenoaks: Arnold)
27. Strand S-E, Jönsson B-A, Ljungberg M and Tennvall J 1993 Radioimmunotherapy dosimetry-A review Acta Oncol. 32 807-17
28. Telenczak P 1991 Apport de la microscopic ionique analytique et des methodes de Monte Carlo (EGS4-PRESTA) pour l'optimisation des parametres dosimetriques en radiotherapie metabolique PhD Thesis Institut Gustave-Roussy
29. Webb S 1993 The Physics of Three Dimensional Radiation Therapy: Conformal Therapy, Radiosurgery and Treatment Planning (Bristol: Institute of Physics)
30. Webb S and Nahum A E 1993 A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density Phys. Med. Biol. 38 653-66
31. Wheldon T E and O'Donoghue J A 1990 The radiobiology of targeted radiotherapy Int. J. Radiat. Biol. 58 1-21
32. 90Y Radiother. Oncol. 21 91-99
33. Zagars G K, Schultheiss T E and Peters L J 1987 Inter-tumour heterogeneity and radiation dosecontrol curves Radiother. Oncol. 8 353-62
34. Zweit J 1996 Radionuclides and carrier molecules for therapy Phys. Med. Biol. 41 1905-14